Can Anti-Nausea meds tame KarXT's stomach woes?
NCT ID NCT07681076
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study tests whether taking anti-nausea medication alongside KarXT—a drug used for schizophrenia—can reduce nausea and vomiting. Healthy volunteers will take KarXT with either scheduled or as-needed antiemetics. The goal is to find a safer, more comfortable way to start treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
KarXT (xanomeline/trospium chloride) with antiemetics (trimethobenzamide, ondansetron, meclizine)
What this could lead to
If successful, this could help doctors manage nausea and vomiting in patients starting KarXT, making treatment more tolerable and improving adherence.
What could go wrong
This is a small, early-phase study in healthy volunteers, not patients. Results may not fully predict real-world side effect management or long-term safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- IPG 1094 PK Study in Healthy Adults - NCT07679113
- Bioequivalence of Sitagliptin/Metformin ER Table NCT07679711
- NNC6022-0001 First Human Dose Study (NCT06336005)
- Kinovea Reliability for Knee & Hip Angles (NCT07676149)
- TEV-56286 Safety Trial in Healthy Volunteers NCT07674940
- ABBV-313 Safety Study in Healthy Adults (NCT07673120)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact